Why the study?
Does aggressive blood pressure control and ACE inhibition prevent the progression of renal failure in patients with chronic renal insufficiency?
Does aggressive blood pressure control and ACE inhibition prevent the progression of renal failure in patients with chronic renal insufficiency?
Aggressive blood pressure control, potentially guided by home monitoring, and ACE inhibition are crucial for slowing the progression of chronic renal insufficiency.
Answers are grounded in this paper and cite their sources.
Supports aggressive BP control and ACE inhibition in chronic renal insufficiency; leaves open optimal targets by disease, sex, and genetics pending randomized trials.
Hypertension is the most common complication of chronic renal insufficiency (CRI) and it accelerates the rate of progression of most forms of CRI. Several large clinical trials have clearly demonstrated the efficacy of antihypertensive treatment for prevention of progression of renal failure. Angiotensin-converting enzyme (ACE) inhibitors may have therapeutic advantages. However, large scale trials include a variety of chronic renal diseases, and the origins of renal diseases are quite diverse. Moreover, the differences in sex, age, race have not been considered. Based on these trials, it was concluded that blood pressure control is the most effective means for the prevention of deterioration of renal dysfunction. Consistent with this view, our recent preliminary data provide evidence that aggressive blood pressure control using self-reported blood pressure values measured by a home blood pressure device is promising to arrest the progression of renal failure in Japanese patients with CRI.
No takes yet. Share an insight, caveat, or question.
Hiromichi Suzuki (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: